UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040642
Receipt number R000046387
Scientific Title Assessment of neointimal coverage using two different imaging modalities at 2-week and 6-month after ultrathin vs thin strut drug-eluting stent implantation in coronary artery disease patients with ST elevation myocardial infarction -high-resolution angioscopy and OCT study-
Date of disclosure of the study information 2020/07/01
Last modified on 2022/12/05 09:16:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of neointimal coverage using two different imaging modalities at 2-week and 6-month after ultrathin vs thin strut drug-eluting stent implantation in coronary artery disease patients with ST elevation myocardial infarction -high-resolution angioscopy and OCT study-

Acronym

NAGAKUTE-CASTLE study

Scientific Title

Assessment of neointimal coverage using two different imaging modalities at 2-week and 6-month after ultrathin vs thin strut drug-eluting stent implantation in coronary artery disease patients with ST elevation myocardial infarction -high-resolution angioscopy and OCT study-

Scientific Title:Acronym

NAGAKUTE-CASTLE study

Region

Japan


Condition

Condition

Acute myocardial infarction

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the neointimal coverage at 14 days after stent placement (Orsiro and Xience) using the imaging devices of OCT/OFDI and angioscopy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Neointimal coverage rate at 2-week after stent implantation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Orsiro stent

Interventions/Control_2

Xience stent

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients with st-elevation myocardial infarction less than 12 hours after onset (Orsiro group: 55 cases, XIENCE group: 55 cases)
(2) Patients who can be followed up in all clinical situations
(3) Patients who can be observed by angiography, OCT/OFDI and angioscopy 2 weeks after PCI
(4) Patients who can be observed by angiography, OCT/OFDI 6 months after surgery
(5) Patients with medical indication of PCI

Key exclusion criteria

(1) Patients who cannot obtain written consent after oral consent by the patient or his/her legal representative
(2) Patients with cardiogenic shock
(3) Hemodialysis patients
(4) Left main lesion / Bifurcation lesion requiring two stents / In-stent restenosis lesion
(5) The target lesion is in the arterial bypass graft or saphenous vein bypass graft, or distal to the graft anastomosis site
(6) Patients who are contraindicated for antiplatelet therapy or anticoagulant therapy
(7) Patients who have difficulty in proper drug therapy
(8) Patients who have a contraindication to contrast agents or have allergies to contrast agents
(9) Patients scheduled for cardiac surgery within 6 months
(10) Patients who have participated in another study and have not completed the observation period in that study
(11) Patients who are judged to be unfavorable for participation in this study by the investigator and investigator

Target sample size

110


Research contact person

Name of lead principal investigator

1st name Tetsuya
Middle name
Last name Amano

Organization

Aichi Medical University

Division name

Cardiology

Zip code

480-1195

Address

1-1 Yazakokarimata Nagakute, Aichi

TEL

0561-62-3311

Email

amanotaha@yahoo.co.jp


Public contact

Name of contact person

1st name Hirohiko
Middle name
Last name Ando

Organization

Aichi Medical University

Division name

Cardiology

Zip code

480-1195

Address

1-1 Yazakokarimata Nagakute, Aichi

TEL

0561-62-3311

Homepage URL


Email

anhiro@aichi-med-u.ac.jp


Sponsor or person

Institute

Aichi Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Aichi Medical University

Address

1-1 Yazakokarimata Nagakute, Aichi

Tel

0561-62-3311

Email

amu_ethics@aichi-med-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知医科大学(愛知県)


Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2020 Year 06 Month 01 Day

Date of IRB

2020 Year 08 Month 05 Day

Anticipated trial start date

2020 Year 07 Month 01 Day

Last follow-up date

2022 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 03 Day

Last modified on

2022 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046387


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name